Join us for the upcoming webinar titled, “Development of digital PCR-based-products to test for cancer-related gene mutations in cancer tissue and liquid biopsies using IDT technology" with Dr. Sung-Hye Hong from Gencurix Inc. What you’ll learn:
In this dynamic session, we’ll discuss how digital PCR (dPCR) is a key technology in cancer research for cancer-associated mutation detection. Dr. Hong will also reveal how IDT’s advanced products are driving innovations in dPCR technology, transforming the landscape of cancer mutation detection.
Medical Science Liaison, Gencurix
Dr. Sung-Hye Hong received her PhD in Cancer Biology from Seoul National University.
She then spent fifteen years as a researcher at the National Cancer Center in Korea, and then two years as a post-doctoral fellow at the National Institutes of Health (NIH) in the U.S.
Throughout her career, she has concentrated on cancer research in the areas of lung, colon, and breast, pancreatic cancers.
Sr. Commercial Product Manager, Core/PCR, IDT
Francisco Cline is a Sr. Commercial Product Manager for PCR Products in IDT’s Core Business Unit. Prior to joining IDT, he was the Sr. Product Manager, Systems and Connectivity at Cepheid. Francisco has more than 16 years of experience in the Molecular Diagnostic Industry; fourteen of those were with Abbott Molecular in Global Product Management, Regional Product Management, Scientific Liaison, Sales and Sales Specialist roles. He also has experience in Finance/Mergers and Acquisitions and Biotechnology Start-up. Francisco received an MBA in Finance and Health Services Management from Duke University and has a degree in Biology (Molecular) from Bucknell University.